Back to Ovarian Cancer
NCT03210298
NCT03210298
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with colorectal cancer (cancer of the colon or rectum)
- You have been diagnosed with ovarian cancer
- You have been diagnosed with gastric cancer (stomach cancer)
- You have been diagnosed with appendiceal cancer (cancer of the appendix)
- You have a condition called pseudomyxoma peritonei (a type of cancer that usually starts in the appendix and spreads to the abdomen)
- You have been diagnosed with malignant mesothelioma (a cancer affecting the lining of certain organs)
- You have been diagnosed with pancreatic cancer
- You have been diagnosed with gallbladder cancer
- You have been diagnosed with small bowel cancer (cancer of the small intestine)
- Your cancer has spread to the peritoneum (the lining of the abdomen), which has been confirmed by a doctor
Who may not be able to join:
- You currently have a bowel obstruction (a blockage in your intestines that is preventing normal digestion)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
UNKNOWN
Phase
Not Applicable
Sponsor
Sabine Rhode
Registry
clinicaltrials_gov
Start date
1 January 2016
Est. completion
1 September 2022
Where this trial is recruiting
🇦🇷 Argentina
🇦🇺 Australia
🇦🇹 Austria
🇧🇪 Belgium
🇩🇰 Denmark
🇫🇷 France
🇩🇪 Germany
🇮🇹 Italy
🇵🇱 Poland
🇷🇺 Russia
🇸🇬 Singapore
🇪🇸 Spain
🇨🇭 Switzerland
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.